Sfoglia per Autore
Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia
2001 Amabile M.; Giannini B.; Testoni N.; Montefusco V.; Rosti G.; Zardini C.; Terragna C.; Buonamici S.; Ottaviani E.; Soverini S.; Fiacchini M.; Bassi S.; De Vivo A.; Trabacchi E.; Saglio G.; Pane F.; Baccarani M.; Tura S.; Martinelii G.
Novel types of bcr-abl transcript with breakpoints in BCR exon 8 found in Philadelphia-positive patients with typical chronic myeloid leukemia retain the sequence encoding for the DBL- and CDC24-homology domains but not the pleckstrin homology one
2002 Martinelli G.; Amabile M.; Giannini B.; Terragna C.; Ottaviani E.; Soverini S.; Saglio G.; Rosti G.; Baccarani M.
Molecular monitoring of acute myeloid leukemia associated with inv(16): Threshold of CBFβ/MYH11 transcript copy number above which relapse occurs and below which continuous complete remission is likely (multiple letters) [8]
2003 Martinelli G.; Buonamici S.; Visani G.; Malagola M.; Piccaluga P.P.; Isidori A.; Bosi C.; Bonifazi F.; Soverini S.; Terragna C.; Amabile M.; Giannini B.; Baccarani M.; Guerrasio A.; Pilatrino C.; Cilloni D.; Gottardi E.; Saglio G.
Rapid detection of Flt3 mutations in acute myeloid leukemia patients by denaturing HPLC
2003 Bianchini M.; Ottaviani E.; Grafone T.; Giannini B.; Soverini S.; Terragna C.; Amabile M.; Piccaluga P.P.; Malagola M.; Rondoni M.; Bosi C.; Baccarani M.; Martinelli G.
Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy.
2004 A.CURTI; A. ISIDORI; E. FERRI; C. TERRAGNA; NEYROZ P.; C. CELLINI; M. RATTA; M. BACCARANI; R. M. LEMOLI
Imatinib Mesylate Determines a High Frequency of Major Molecular Responses in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Phase Chronic Myeloid Leukemia on Behalf of the GIMEMA CML WP.
2005 Iacobucci, I; Testoni, N; Rosti, G; Amabile, M; Poerio, A; Soverini, S; Colarossi, S; Gnani, A; Ottaviani, E; Castagnetti, F; Terragna, C; Renzulli, M; Grafone, T; Cilloni, D; Pane, F; Saglio, G; Baccarani, M; Martinelli, G
Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma.
2005 CAVO M; ZAMAGNI E; TOSI P; TACCHETTI P; CELLINI C; CANGINI D; DE VIVO A; TESTONI N; NICCI C; TERRAGNA C; GRAFONE T; PERRONE G; CECCOLINI M; TURA S; BACCARANI M.; BOLOGNA STUDY.
Poor outcome with front-line autologous transplantation in t(4;14) multiple myeloma: low complete remission rate and short duration of remission.
2006 Cavo M; Terragna C; Renzulli M; Zamagni E; Tosi P; Testoni N; Nicci C; Cangini D; Tacchetti P; Grafone T; Cellini C; Ceccolini M; Perrone G; Martinelli G; Baccarani M; Guardigni L.
Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment.
2006 IACOBUCCI I; ROSTI G; AMABILE M; POERIO A; SOVERINI S; CILLONI D; TESTONI N; ABRUZZESE E; MONTEFUSCO E; OTTAVIANI E; IULIANO F; RUSSO D; GOBBI M; ALIMENA G; MARTINO B; TERRAGNA C; PANE F; SAGLIO G; BACCARANI M; MARTINELLI G
Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides.
2007 Curti A; Tosi P; Comoli P; Terragna C; Ferri E; Cellini C; Massaia M; D'Addio A; Giudice V; Di Bello C; Cavo M; Conte R; Gugliotta G; Baccarani M; Lemoli RM.
Prediction of response to primary therapy with thalidomide-dexamethasone (thal-dex) for newly diagnosed multiple myeloma by gene expression profiling (gep)
2007 Terragna, C.; Renzulli, M.; Remondini, D.; Tagliafico, E.; Roncaglia, E.; Tosi, P.; Zamagni, E.; Tacchetti, P.; Perrone, G.; Ceccolini, M.; Brioli, Am.; Martinelli, G.; Baccarani, M.; Cavo, M.
Prediction of response to primary therapy with thalidomide-dexamethasone (thal-dex) for newly diagnosed multiple myeloma by gene expression profiling (gep)
2007 Terragna C.; Renzulli M.; Remondini D.; Tagliafico E.; Roncaglia E.; Tosi P.; Zamagni E.; Tacchetti P.; Perrone G.; Ceccolini M.; Brioli AM.; Martinelli G.; Baccarani M.; Cavo M.
Gene expression profiling (gep) of myeloma (MM) cells to predict attainment near complete response to primary therapy with thalidomide-dexamethasone (thal-dex) for newly diagnosed MM
2007 C. Terragna; M. Renzulli; D. Remondini; E. Tagliafico; E. Roncaglia; P. Tosi; E. Zamagni; P. Tacchetti; G. Perrone; M. Ceccolini; G. Martinelli; M. Baccarani; M. Cavo
Positive Selection and Transplantation of Autologous Highly Purified CD133+ Stem Cells in Resistant/Relapsed Chronic Lymphocytic Leukemia Patients Results in Rapid Hematopoietic Reconstitution without an Adequate Leukemic Cell Purging
2007 Isidori, A; Motta, M R; Tani, M; Terragna, C; Zinzani, P; Curti, A; Rizzi, S; Taioli, S; Giudice, V; D'Addio, A; Gugliotta, G; Conte, R; Baccarani, M; Lemoli, R. M.
Evaluation of bone disease in multiple myeloma patients carrying the t(4;14) chromosomal translocation.
2008 Tosi P; Terragna C; Testoni N; Zamagni E; Renzulli M; Tacchetti P; Montanari E; Perrone G; Ceccolini M; Brioli A; Pallotti MC; Tura S; Baccarani M; Cavo M.
New drugs to overcome meccanisms of resistance in Ph+ leukemia: Bosutinib
2008 Martinelli, G.; Iacobucci, I.; Cilloni, D.; Giannoulia, P.; Soverini, S.; Piccaluga, P.P.; Papayannidis, C.; Paolini, S.; Terragna, C.; Amabile, M.; Colarossi, S.; Gnani, A.; Pane, F.; Saglio, G.; Baccarani, M.
Proteasome inhibitors: Bortezomib in multiple myeloma
2008 Cavo M.; Pallotti M.C.; Pantani L.; Petrucci A.; Brioli A.; Terragna C.; Testoni N.; Marzocchi G.; Durante S.; Ceccolini M.; Perrone G.; Tacchetti P.; Zamagni E.; Tosi P.; Baccarani M.
The road to cure in multiple myeloma: Incorporation of novel agents into autologous stem cell transplantation
2009 Cavo M.; Zamagni E.; Tacchetti P.; Brioli A.; Pallotti C.; Pantani L.; Ceccolini M.; Petrucci A.; Testoni N.; Terragna C.; Marzocchi G.; Durante S.; Tosi P.; Baccarani M.
CLINICAL OUTCOMES PREDICTION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH THALIDOMIDE-DEXAMETHASONE AND AUTOLOGOUS STEM CELL TRANSPLANTATION BY 8-GENE SIGNATURE OF CD138+ PLASMA CELLS
2010 Terragna C.; Remondini D.; Martinelli G.; Tosi P.; Zamagni E.; Tacchetti P.; Perrone G.; Brioli A.; Ceccolini M.; Testoni N.; Marzocchi G.; Castellani G.; Durante S.; Di Raimondo F.; Patriarca F.; Catalano L.; Masini L.; Ledda A.; Angelucci E.; Galieni P.; Gozzetti A.; Baccarani M.; Cavo M.
Association between genotypes and response to the treatment in a subset of previously untreated chronic myeloid leukemia patients enrolled into the TOPS trial.
2010 ANGELINI S.; S. POVERINI; E. TURRINI; G. PERINI; F. PANE; F. QUARANTELLI; T. HUGHES; D. WHITE; D.W. KIM; H. GOH; J. RADICH; L. BEPPU; G. SAGLIO; D. CILLONI; C. TERRAGNA; I. IACOBUCCI; P. HRELIA; G. CANTELLI FORTI; T. KALEBIC; M. THORNQUIST; M. BACCARANI; G. MARTINELLI
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
---|---|---|---|---|---|---|
Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia | Amabile M.; Giannini B.; Testoni N.; Montefusco V.; Rosti G.; Zardini C.; Terragna C.; Buonamici ...S.; Ottaviani E.; Soverini S.; Fiacchini M.; Bassi S.; De Vivo A.; Trabacchi E.; Saglio G.; Pane F.; Baccarani M.; Tura S.; Martinelii G. | 2001-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
Novel types of bcr-abl transcript with breakpoints in BCR exon 8 found in Philadelphia-positive patients with typical chronic myeloid leukemia retain the sequence encoding for the DBL- and CDC24-homology domains but not the pleckstrin homology one | Martinelli G.; Amabile M.; Giannini B.; Terragna C.; Ottaviani E.; Soverini S.; Saglio G.; Rosti ...G.; Baccarani M. | 2002-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
Molecular monitoring of acute myeloid leukemia associated with inv(16): Threshold of CBFβ/MYH11 transcript copy number above which relapse occurs and below which continuous complete remission is likely (multiple letters) [8] | Martinelli G.; Buonamici S.; Visani G.; Malagola M.; Piccaluga P.P.; Isidori A.; Bosi C.; Bonifaz...i F.; Soverini S.; Terragna C.; Amabile M.; Giannini B.; Baccarani M.; Guerrasio A.; Pilatrino C.; Cilloni D.; Gottardi E.; Saglio G. | 2003-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
Rapid detection of Flt3 mutations in acute myeloid leukemia patients by denaturing HPLC | Bianchini M.; Ottaviani E.; Grafone T.; Giannini B.; Soverini S.; Terragna C.; Amabile M.; Piccal...uga P.P.; Malagola M.; Rondoni M.; Bosi C.; Baccarani M.; Martinelli G. | 2003-01-01 | CLINICAL CHEMISTRY | - | 1.01 Articolo in rivista | - |
Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy. | A.CURTI; A. ISIDORI; E. FERRI; C. TERRAGNA; NEYROZ P.; C. CELLINI; M. RATTA; M. BACCARANI; R. M. ...LEMOLI | 2004-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
Imatinib Mesylate Determines a High Frequency of Major Molecular Responses in Newly Diagnosed Philadelphia Chromosome-Positive Chronic Phase Chronic Myeloid Leukemia on Behalf of the GIMEMA CML WP. | Iacobucci, I; Testoni, N; Rosti, G; Amabile, M; Poerio, A; Soverini, S; Colarossi, S; Gnani, A; O...ttaviani, E; Castagnetti, F; Terragna, C; Renzulli, M; Grafone, T; Cilloni, D; Pane, F; Saglio, G; Baccarani, M; Martinelli, G | 2005-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma. | CAVO M; ZAMAGNI E; TOSI P; TACCHETTI P; CELLINI C; CANGINI D; DE VIVO A; TESTONI N; NICCI C; TERR...AGNA C; GRAFONE T; PERRONE G; CECCOLINI M; TURA S; BACCARANI M.; BOLOGNA STUDY. | 2005-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
Poor outcome with front-line autologous transplantation in t(4;14) multiple myeloma: low complete remission rate and short duration of remission. | Cavo M; Terragna C; Renzulli M; Zamagni E; Tosi P; Testoni N; Nicci C; Cangini D; Tacchetti P; Gr...afone T; Cellini C; Ceccolini M; Perrone G; Martinelli G; Baccarani M; Guardigni L. | 2006-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatment. | IACOBUCCI I; ROSTI G; AMABILE M; POERIO A; SOVERINI S; CILLONI D; TESTONI N; ABRUZZESE E; MONTEFU...SCO E; OTTAVIANI E; IULIANO F; RUSSO D; GOBBI M; ALIMENA G; MARTINO B; TERRAGNA C; PANE F; SAGLIO G; BACCARANI M; MARTINELLI G | 2006-01-01 | JOURNAL OF CLINICAL ONCOLOGY | - | 1.01 Articolo in rivista | - |
Phase I/II clinical trial of sequential subcutaneous and intravenous delivery of dendritic cell vaccination for refractory multiple myeloma using patient-specific tumour idiotype protein or idiotype (VDJ)-derived class I-restricted peptides. | Curti A; Tosi P; Comoli P; Terragna C; Ferri E; Cellini C; Massaia M; D'Addio A; Giudice V; Di Be...llo C; Cavo M; Conte R; Gugliotta G; Baccarani M; Lemoli RM. | 2007-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
Prediction of response to primary therapy with thalidomide-dexamethasone (thal-dex) for newly diagnosed multiple myeloma by gene expression profiling (gep) | Terragna, C.; Renzulli, M.; Remondini, D.; Tagliafico, E.; Roncaglia, E.; Tosi, P.; Zamagni, E.; ...Tacchetti, P.; Perrone, G.; Ceccolini, M.; Brioli, Am.; Martinelli, G.; Baccarani, M.; Cavo, M. | 2007-01-01 | - | - | 4.02 Riassunto (Abstract) | - |
Prediction of response to primary therapy with thalidomide-dexamethasone (thal-dex) for newly diagnosed multiple myeloma by gene expression profiling (gep) | Terragna C.; Renzulli M.; Remondini D.; Tagliafico E.; Roncaglia E.; Tosi P.; Zamagni E.; Tacchet...ti P.; Perrone G.; Ceccolini M.; Brioli AM.; Martinelli G.; Baccarani M.; Cavo M. | 2007-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
Gene expression profiling (gep) of myeloma (MM) cells to predict attainment near complete response to primary therapy with thalidomide-dexamethasone (thal-dex) for newly diagnosed MM | C. Terragna; M. Renzulli; D. Remondini; E. Tagliafico; E. Roncaglia; P. Tosi; E. Zamagni; P. Tacc...hetti; G. Perrone; M. Ceccolini; G. Martinelli; M. Baccarani; M. Cavo | 2007-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
Positive Selection and Transplantation of Autologous Highly Purified CD133+ Stem Cells in Resistant/Relapsed Chronic Lymphocytic Leukemia Patients Results in Rapid Hematopoietic Reconstitution without an Adequate Leukemic Cell Purging | Isidori, A; Motta, M R; Tani, M; Terragna, C; Zinzani, P; Curti, A; Rizzi, S; Taioli, S; Giudice,... V; D'Addio, A; Gugliotta, G; Conte, R; Baccarani, M; Lemoli, R. M. | 2007-01-01 | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | - | 1.01 Articolo in rivista | - |
Evaluation of bone disease in multiple myeloma patients carrying the t(4;14) chromosomal translocation. | Tosi P; Terragna C; Testoni N; Zamagni E; Renzulli M; Tacchetti P; Montanari E; Perrone G; Ceccol...ini M; Brioli A; Pallotti MC; Tura S; Baccarani M; Cavo M. | 2008-01-01 | EUROPEAN JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
New drugs to overcome meccanisms of resistance in Ph+ leukemia: Bosutinib | Martinelli, G.; Iacobucci, I.; Cilloni, D.; Giannoulia, P.; Soverini, S.; Piccaluga, P.P.; Papaya...nnidis, C.; Paolini, S.; Terragna, C.; Amabile, M.; Colarossi, S.; Gnani, A.; Pane, F.; Saglio, G.; Baccarani, M. | 2008-01-01 | HEMATOLOGY MEETING REPORTS | - | 4.01 Contributo in Atti di convegno | - |
Proteasome inhibitors: Bortezomib in multiple myeloma | Cavo M.; Pallotti M.C.; Pantani L.; Petrucci A.; Brioli A.; Terragna C.; Testoni N.; Marzocchi G....; Durante S.; Ceccolini M.; Perrone G.; Tacchetti P.; Zamagni E.; Tosi P.; Baccarani M. | 2008-01-01 | HEMATOLOGY MEETING REPORTS | - | 1.01 Articolo in rivista | - |
The road to cure in multiple myeloma: Incorporation of novel agents into autologous stem cell transplantation | Cavo M.; Zamagni E.; Tacchetti P.; Brioli A.; Pallotti C.; Pantani L.; Ceccolini M.; Petrucci A.;... Testoni N.; Terragna C.; Marzocchi G.; Durante S.; Tosi P.; Baccarani M. | 2009-01-01 | HEMATOLOGY MEETING REPORTS | - | 1.01 Articolo in rivista | - |
CLINICAL OUTCOMES PREDICTION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH THALIDOMIDE-DEXAMETHASONE AND AUTOLOGOUS STEM CELL TRANSPLANTATION BY 8-GENE SIGNATURE OF CD138+ PLASMA CELLS | Terragna C.; Remondini D.; Martinelli G.; Tosi P.; Zamagni E.; Tacchetti P.; Perrone G.; Brioli A....; Ceccolini M.; Testoni N.; Marzocchi G.; Castellani G.; Durante S.; Di Raimondo F.; Patriarca F.; Catalano L.; Masini L.; Ledda A.; Angelucci E.; Galieni P.; Gozzetti A.; Baccarani M.; Cavo M. | 2010-01-01 | HAEMATOLOGICA | - | 4.02 Riassunto (Abstract) | - |
Association between genotypes and response to the treatment in a subset of previously untreated chronic myeloid leukemia patients enrolled into the TOPS trial. | ANGELINI S.; S. POVERINI; E. TURRINI; G. PERINI; F. PANE; F. QUARANTELLI; T. HUGHES; D. WHITE; D....W. KIM; H. GOH; J. RADICH; L. BEPPU; G. SAGLIO; D. CILLONI; C. TERRAGNA; I. IACOBUCCI; P. HRELIA; G. CANTELLI FORTI; T. KALEBIC; M. THORNQUIST; M. BACCARANI; G. MARTINELLI | 2010-01-01 | - | s.n | 4.02 Riassunto (Abstract) | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile